Pro Health Tips
Wednesday, 22 December 2021
COVID-19: Oxford-AstraZeneca Begins Work on Omicron-Targeted Vaccine
The pharma giant AstraZeneca and Oxford University have come together to develop a COVID-19 vaccine that specifically targets the Omicron variant.
from Medindia Health News https://ift.tt/3picV3k
No comments:
Post a Comment
‹
›
Home
View web version
The pharma giant AstraZeneca and Oxford University have come together to develop a COVID-19 vaccine that specifically targets the Omicron variant.
No comments:
Post a Comment